SCHEMBL6506563

SCHEMBL6506563

NC(=O)Nc1cn(-c2cccc(-c3ccc(Cl)cc3Cl)c2)nc1C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 4/20 0.46
ITK Q08881 1/20 0.42
PARP1 P09874 1/20 0.42
PARP2 Q9UGN5 1/20 0.42
PARP3 Q9Y6F1 1/20 0.42
MARS1 P56192 3/20 0.41
HPGD P15428 2/20 0.40
CNR1 P21554 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
IRAK4 Q9NWZ3 2/20 0.39
IKBKB O14920 1/20 0.39
GAA P10253 2/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
AURKA O14965 1/20 0.38
PTGES2 Q9H7Z7 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6499612 0.88 MARS1 (0.44) ITKMARS1HPGDCNR1KDM4E
SCHEMBL6499924 0.88 IKBKB (0.48) SCN9AITKPARP1PARP2PARP3
SCHEMBL6498355 0.87 KDM4E (0.47) SCN9AITKPARP1PARP2PARP3
SCHEMBL6468728 0.87 IKBKB (0.42) SCN9AITKKDM4EALDH1A1MAPT
SCHEMBL6506967 0.85 PDE4D (0.51) SCN9AITKHPGDKDM4EALDH1A1
SCHEMBL6508463 0.85 ITK (0.45) SCN9AITKPARP1PARP2PARP3
SCHEMBL6502841 0.85 SCN9A (0.53) SCN9AITKPARP1PARP2PARP3
SCHEMBL6497902 0.83 SCN9A (0.43) SCN9AITKPARP1PARP2PARP3
SCHEMBL6502010 0.83 SCN9A (0.51) SCN9AITKKDM4EALDH1A1LMNA
SCHEMBL6506697 0.81 SCN9A (0.50) SCN9AITKKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 SCN9A 4159/4885ITK 4236/4885PARP1 1904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.